ACC Decision Pathway Shows Safety, Efficacy in ED Patients with Chest Pain: Observational Cohort Study

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650 Annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

ACC Decision Pathway Shows Safety, Efficacy in ED Patients with Chest Pain: Observational Cohort Study

Posted: 03/25/2024
Author:
Jason Wermers, CRTonline.org
News Articles Acute Coronary Syndrome Coronary 2024 CAD ACS & AMI

Results suggest pathway might not be safe to use in patients with known CAD

The American College of Cardiology (ACC) Expert Consensus Decision Pathway on the evaluation of possible acute coronary syndrome in adult patients presenting with chest pain to the emergency department (ED) demonstrated safety and efficacy in a validation study.
1-3 of 2758 results
1 2 3 4 5 Next »

Hospitalized COVID-19 Patients at Greater Risk for CAD, MACE: UK Biobank Analysis

Oct 09, 2024 by
Bailey G. Salimes, CRTonline.org

Patients hospitalized for COVID-19 are at greater risk for coronary artery disease, and patients with non-O blood types are at an additional risk for post-acute myocardial infarction and stroke, a new analysis from the UK Biobank shows.

BRIGHT-4 External Confirmation: Mortality, Bleeding Reduced, no Increase in Ischemic Events, in STEMI Patients Receiving Bivalirudin Plus High-Dose Infusion Post-PCI

Oct 09, 2024 by
Bailey G. Salimes, CRTonline.org

External validation of the BRIGHT-4 results shows that patients with ST-segment myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (PCI) who receive bivalirudin plus a high-dose infusion 2- to 4-hours post-PCI have reduced cardiac mortality and major bleeding, and no increase in ischemic events, compared with patients who receive heparin monotherapy with provisional glycoprotein IIb/IIIa inhibitor (GPI) use.

Higher GDMT Score Linked to Lower Mortality, Hospitalization and Costs, Study Suggests

Sep 30, 2024 by
Will Chu, CRTonline.org

Findings from a new study reveal an association between higher guideline-directed medical therapy (GDMT) score at discharge with lower mortality, hospitalization, more home time and lower costs.

1-3 of 2758 results
1 2 3 4 5 Next »

Most Viewed Pages

Hospitalized COVID-19 Patients at Greater Risk for CAD, MACE: UK Biobank Analysis

BRIGHT-4 External Confirmation: Mortality, Bleeding Reduced, no Increase in Ischemic Events, in STEMI Patients Receiving Bivalirudin Plus High-Dose Infusion Post-PCI

Fusion Mixed Reality: A Novel Approach to Merge the Physical and Virtual Cath Lab

Kissing Stenting for Left Main Carina Perforation

Late Gadolinium Enhancement May Improve Risk Stratification for Children with Hypertrophic Cardiomyopathy at Risk of Sudden Cardiac Death – Retrospective Study

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

ACC Decision Pathway Shows Safety, Efficacy in ED Patients with Chest Pain: Observational Cohort Study

Results suggest pathway might not be safe to use in patients with known CAD

Hospitalized COVID-19 Patients at Greater Risk for CAD, MACE: UK Biobank Analysis

BRIGHT-4 External Confirmation: Mortality, Bleeding Reduced, no Increase in Ischemic Events, in STEMI Patients Receiving Bivalirudin Plus High-Dose Infusion Post-PCI

Higher GDMT Score Linked to Lower Mortality, Hospitalization and Costs, Study Suggests

Most Viewed Pages

Explore the Site

Stay Connected